Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Feb 13, 2025

SELL
$40.25 - $52.99 $496,765 - $654,002
-12,342 Closed
0 $0
Q1 2024

Feb 13, 2025

SELL
$47.98 - $54.4 $215,910 - $244,800
-4,500 Reduced 26.72%
12,342 $669 Million
Q4 2023

Feb 13, 2025

SELL
$48.48 - $57.85 $163,038 - $194,549
-3,363 Reduced 16.64%
16,842 $864 Million
Q3 2023

Feb 13, 2025

SELL
$57.89 - $64.73 $52,911 - $59,163
-914 Reduced 4.33%
20,205 $1.17 Billion
Q2 2023

Feb 13, 2025

BUY
$63.71 - $70.74 $113,403 - $125,917
1,780 Added 9.2%
21,119 $1.35 Billion
Q1 2023

Feb 13, 2025

BUY
$65.71 - $74.53 $102,507 - $116,266
1,560 Added 8.77%
19,339 $1.34 Billion
Q4 2022

Feb 13, 2025

BUY
$68.48 - $81.09 $78,272 - $92,685
1,143 Added 6.87%
17,779 $1.28 Billion
Q3 2022

Feb 13, 2025

SELL
$0.13 - $76.84 $46 - $27,431
-357 Reduced 2.1%
16,636 $1.18 Billion
Q2 2022

Feb 13, 2025

BUY
$72.62 - $79.98 $12,418 - $13,676
171 Added 1.02%
16,993 $1.31 Billion
Q1 2022

Feb 13, 2025

SELL
$61.48 - $73.72 $16,538 - $19,830
-269 Reduced 1.57%
16,822 $1.23 Billion
Q4 2021

Feb 13, 2025

SELL
$53.63 - $62.52 $10,511 - $12,253
-196 Reduced 1.13%
17,091 $1.07 Billion
Q3 2021

Feb 13, 2025

BUY
$59.17 - $69.31 $59 - $69
1 Added 0.01%
17,287 $1.02 Billion
Q2 2021

Feb 13, 2025

SELL
$61.91 - $67.42 $6,562 - $7,146
-106 Reduced 0.61%
17,286 $1.16 Billion
Q1 2021

Feb 13, 2025

BUY
$59.34 - $66.74 $9,672 - $10,878
163 Added 0.95%
17,392 $1.1 Billion
Q4 2020

Feb 13, 2025

SELL
$57.74 - $65.43 $79,912 - $90,555
-1,384 Reduced 7.44%
17,229 $1.07 Billion
Q3 2020

Feb 13, 2025

SELL
$57.43 - $63.64 $31,643 - $35,065
-551 Reduced 2.88%
18,613 $1.12 Billion
Q2 2020

Feb 13, 2025

BUY
$54.82 - $64.09 $2,466 - $2,884
45 Added 0.24%
19,164 $1.13 Billion
Q1 2020

Feb 13, 2025

SELL
$46.4 - $67.43 $5,800 - $8,428
-125 Reduced 0.65%
19,119 $1.07 Billion
Q3 2019

Feb 13, 2025

SELL
$42.77 - $50.71 $48,586 - $57,606
-1,136 Reduced 5.57%
19,244 $976 Million
Q2 2019

Feb 13, 2025

SELL
$44.62 - $49.34 $146,487 - $161,983
-3,283 Reduced 13.87%
20,380 $924 Million
Q1 2019

Feb 13, 2025

BUY
$45.12 - $53.8 $1.07 Million - $1.27 Million
23,663 New
23,663 $1.13 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ategra Capital Management, LLC Portfolio

Follow Ategra Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ategra Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ategra Capital Management, LLC with notifications on news.